Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unraveling the SIGNature of ALzheimer's Disease: Integrating Multimodal Biomarkers Through Machine Learning

NCT07402161 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT07402161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unraveling the SIGNature of ALzheimer's Disease: Integrating Multimodal Biomarkers Through Machine Learning
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
March 1, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subjective cognitive complaints (sccs), subjective cognitive concerns, subjective cognitive decline (scd), subjective cognitive impairment, subjective memory complaint, subjective memory decline